中国生物工程杂志

［1］ Daniels T R, Delgado T, Rodriguez J A, et al. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol, 2006, 121(2): 144158. 
［2］ Daniels T R, Delgado T, Helguera G, et al. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol, 2006, 121(2): 159176. 
［3］ 石屹峰，边蕾. 以人血清白蛋白为载体的长效蛋白质药物的研究进展.中国医药生物技术，2008，3(6)：454456. Shi Y F，Bian L. Chin Med Biotechnol, 2008, 3(6): 454456. 
［4］ Newton D L, Nicholls P J, Rybak S M, et al. Expression and characterization of recombinant human eosinophilderived neurotoxin and eosinophilderived neurotoxinantitransferrin receptor sFv. J Biol Chem, 1994, 269(43): 2673926745. 
［5］ Scott J K, Smith G P. Searching for peptide ligands with an epitope library. Science, 1990, 249(4967): 386390. 
［6］ Cortese R, Monaci P, Nicosia A, et al. Identification of biologically active peptides using random libraries displayed on phage. Curr Opin Biotechnol, 1995, 6(1): 7380. 
［7］ Kehoe J W, Kay B K. Filamentous phage display in the new millennium. Chem Rev, 2005, 105(11): 40564072. 
［8］ Yi G, Qian J, Wang Z, et al. A phagedisplayed peptide can inhibit infection by white spot syndrome virus of shrimp. J Gen Virol, 2003, 84: 25452553. 
［9］ 裘锋平，詹金彪，王克夷. 利用噬菌体展示技术筛选胰岛素模拟肽. 中国生物化学与分子生物学报，2006，22(8)：647651. Qiu F P，Zhan J B, Wang K Y. Chinese Journal of Biochemistry and Molecular Biology, 2006, 22(8): 647651. 
［10］ Dyson M R, Germaschewski V, Murray K. Direct measurement via phage titre of the dissociation constants in solution of fusion phagesubstrate complexes. Nucleic Acids Res, 1995, 23(9): 15311535. 
［11］ Wilson W D. Analyzing biomolecular interactions. Science, 2002, 295(5562): 21032105. 
［12］ Mccloskey N, Turner M W, Goldblat T D. Correlation between the avidity of mousehuman chimeric IgG subclass monoclonal antibodies measured by solidphase elution ELISA and biospecific interaction analysis (BIA). J Immunol Methods, 1997, 205(1): 6772. 
［13］ Wang Gang, Wang Yan, Li Chunying, et al. Thiocyanate elution measurement of relative affinity of phage antibodies. Chinese Journal of Biotechnology, 2004, 20(3): 429433. 
［14］ 边蕾，石屹峰. 蛋白质药物长效化技术的现状和进展. 中国生物工程杂志，2009，29(1)：114118. Bian L, Shi Y F. China Biotechnology, 2009, 29(1): 114118. 
［15］ Nguyen A, Reyes A E, Zhang M, et al. The pharmacokinetics of an albuminbinding Fab (AB.Fab) can be modulated as a function of affinity for albumin. Protein Eng Des Sel, 2006, 19(7): 291297. 
［16］ Macedo M F, Desousa M. Transferrin and the transferrin receptor: of magic bullets and other concerns. Inflamm Allergy Drug Targets, 2008, 7(1): 4152. 
［17］ 颜冰，赵莉霞，黄培堂. 转铁蛋白受体单链抗体与链亲和素融合基因的克隆及其在大肠杆菌中的可溶性表达. 生物技术通讯，2006，17(5)：688691. Yan B, Zhao L X, Huang P T. Letters in Biotechnology, 2006, 17(05): 688691.